肺纤维化的诊治新进展  

New Progress in Diagnosis and Treatment of Pulmonary Fibrosis

作　　者：李翠东 刘桂桃[1] LI Cui-dong;LIU Gui-tao(The Fifth Affiliated Hospital of Xinjiang Medical University,Urumqi Xinjiang 830000)

机构地区：[1]新疆医科大学第五附属医院,新疆乌鲁木齐830000

出　　处：《世界最新医学信息文摘》2018年第18期75-77,共3页World Latest Medicine Information Electronic Version

摘　　要：肺纤维化是间质性疾病的一种,属于纤维增殖性疾病的范畴,发病原因不明但发病率及死亡率逐年升高,大部分患者发病后3-8年死亡,平均生存时间2.5-3年。随着对该疾病诊断及治疗方面研究的深入进行,新的诊断及治疗方法层出不穷,本文就肺纤维化的诊治新进展作一综述。Pulmonary fibrosis is an interstitial disease,which belongs to the proliferation of disease category,but the pathogenesis of unexplained morbidity and mortality increased year by year,the majority of patients 3-8 years after death,the average survival time of 2.5-3.With the research of this disease on deepening,diagnosis and treatment of pulmonary fibrosis with new progress,this article reviews the progress in diagnosis and treatment of pulmonary fibrosis.

关 键 词：肺纤维化 诊断 治疗 

分 类 号：R563.9[医药卫生—呼吸系统]